Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?

Background: The clinical impact of fused PET/CT data on staging and patient management of Hodgkin disease (HD) and non-Hodgkin lymphoma (NHL) was assessed. Patients and methods: A total of 103 consecutive patients with newly diagnosed NHL (n = 68) and HD (n = 35) were assessed retrospectively. Three...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2006-01, Vol.17 (1), p.117-122
Hauptverfasser:	Raanani, P., Shasha, Y., Perry, C., Metser, U., Naparstek, E., Apter, S., Nagler, A., Polliack, A., Ben-Bassat, I., Even-Sapir, E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic agents Biological and medical sciences Female Fluorodeoxyglucose F18 Follow-Up Studies Hematologic and hematopoietic diseases Hodgkin disease Hodgkin Disease - diagnostic imaging Hodgkin Disease - pathology Humans Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphoma, Non-Hodgkin - diagnostic imaging Lymphoma, Non-Hodgkin - pathology Male Medical sciences Middle Aged Neoplasm Staging non-Hodgkin lymphoma PET/CT Pharmacology. Drug treatments Positron-Emission Tomography - methods Prognosis Radiopharmaceuticals Retrospective Studies staging Tomography, X-Ray Computed
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!